These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15264983)

  • 1. Advancements in the battle against severe acute respiratory syndrome.
    Hui DS; Wong GW
    Expert Opin Pharmacother; 2004 Aug; 5(8):1687-93. PubMed ID: 15264983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on severe acute respiratory syndrome (SARS).
    Hui DS
    Monaldi Arch Chest Dis; 2005 Sep; 63(3):149-57. PubMed ID: 16312205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral drugs in severe acute respiratory syndrome].
    Yazdanpanah Y; Guéry B
    Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
    Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
    Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in Children: Clinical Approach and Management.
    Sankar J; Dhochak N; Kabra SK; Lodha R
    Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
    Zimmermann P; Curtis N
    Pediatr Infect Dis J; 2020 May; 39(5):355-368. PubMed ID: 32310621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe acute respiratory syndrome.
    Lai ST
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):583-91. PubMed ID: 16172857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.
    Chan KS; Lai ST; Chu CM; Tsui E; Tam CY; Wong MM; Tse MW; Que TL; Peiris JS; Sung J; Wong VC; Yuen KY
    Hong Kong Med J; 2003 Dec; 9(6):399-406. PubMed ID: 14660806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
    Guihot A; Bricaire F; Li T; Bossi P
    Presse Med; 2004 Mar; 33(5):344-51. PubMed ID: 15041887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
    Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
    J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine.
    Tsunetsugu-Yokota Y; Ohnishi K; Takemori T
    Rev Med Virol; 2006; 16(2):117-31. PubMed ID: 16518829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Li H; Wang YM; Xu JY; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):170-172. PubMed ID: 32164080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome in children.
    Wong GW; Li AM; Ng PC; Fok TF
    Pediatr Pulmonol; 2003 Oct; 36(4):261-6. PubMed ID: 12950037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(7-8):42-6. PubMed ID: 22359870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.